Enliven Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
29.42
9.08 (44.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
44.64%
-1.23%
1W
34.58%
-2.45%
1M
59.72%
-1.5%
YTD
30.76%
-0.69%
1Y
30.29%
12.16%
3Y
568.64%
64.35%
5Y
-84.9%
74.91%
10Y
-84.9%
261.61%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
45.14%
0%
45.14%
6 Months
23.67%
0%
23.67%
1 Year
30.29%
0%
30.29%
2 Years
36.08%
0%
36.08%
3 Years
568.64%
0%
568.64%
4 Years
-16.89%
0%
-16.89%
5 Years
-84.9%
0%
-84.9%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary